Trial Profile
Secondary Protective effect of ca-antagonist for ischemic heart attack randomized parallel comparison with beta-blocker trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Atenolol (Primary) ; Benidipine (Primary)
- Indications Angina pectoris; Ischaemic heart disorders; Myocardial infarction
- Focus Therapeutic Use
- Acronyms SPECIAL
- 13 Jun 2009 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan
- 06 Dec 2007 New trial record.